Physician profile
Devi Nair
NPI 1538357470
$1,756,172.70
in general payments reported to CMS, 2019-2025
45 companies · $420K in 2025
The $420K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $151K · 2020: $96K · 2021: $165K · 2022: $264K · 2023: $243K · 2024: $418K · 2025: $420K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $401K · Consulting Fee: $362K · Travel and Lodging: $257K · Food and Beverage: $47K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,400 · Honoraria: $2,500 · Grant: $2,195 · Education: $1,382 · Other payment types: $27.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $401,038.75 |
| Consulting Fee | $361,750.85 |
| Travel and Lodging | $257,053.60 |
| Food and Beverage | $47,264.83 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,400.00 |
| Honoraria | $2,500.00 |
| Grant | $2,195.00 |
| Education | $1,382.04 |
| Other payment types | $27.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $621,696.33 | 2019-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Abbott Laboratories | $438,274.87 | 2019-2025 | Aveir, Amplatzer Amulet, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $342,519.26 | 2021-2025 | Affera Mapping System, Arctic Front Advance, Micra |
| Biosense Webster, INC. | $114,735.40 | 2019-2025 | Carto 3, Thermocool Sf, Thermocool Smarttouch |
| Medtronic Vascular, INC. | $82,890.84 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $49,924.40 | 2023-2025 | Acuson Origin Diagnostic Ultrasound System, Acuson Sc2000 Diagnostic Ultrasound System |
| Volta Medical INC | $39,729.19 | 2022-2025 | Vx1 |
| Janssen Pharmaceuticals, INC | $22,850.31 | 2019-2022 | |
| Medical Device Business Services, INC. | $15,751.60 | 2022-2024 | Carto 3 |
| Atricure, INC. | $7,536.50 | 2023-2025 | Lariat Rs, Synergy Ablation System, Epi-Ease Epicardial Access System |
| Baylis Medical Company INC | $4,530.48 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $3,250.00 | 2019-2023 | |
| Pfizer INC. | $2,888.48 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $2,500.00 | 2025 | Optimizer |
| Ebr Systems, INC. | $2,079.18 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $1,925.00 | 2020 | |
| Janssen Global Services, LLC | $675.00 | 2024 | |
| Cvrx, INC. | $387.08 | 2021-2025 | Barostim Neo System |
| Acutus Medical, INC. | $360.24 | 2020-2022 | |
| Biotronik INC. | $296.77 | 2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Abiomed | $244.31 | 2019-2023 | Impella |
| Angiodynamics, INC. | $202.60 | 2024-2025 | Alphavac, Angiovac |
| Cordis US Corp. | $167.93 | 2023-2025 | Mynx Control Venous, Mynx Control, Selution Slrpta |
| Philips North America LLC | $124.69 | 2024-2025 | (Am5) Lead Management, Lm Undivided, Laser Parts Other |
| Penumbra, INC. | $121.39 | 2023 | Indigo System, Smart Coil |
| Novartis Pharmaceuticals Corporation | $100.54 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $92.30 | 2019 | |
| Flowphysix INC | $86.49 | 2025 | Flowrunner |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.01 | 2019-2020 | |
| Terumo Medical Corporation | $35.24 | 2025 | Metacross Otw, R2p Misago, Azur Cx Detachable |
| Stereotaxis INC | $27.41 | 2024 | Genesis |
| Avinger INC. | $24.61 | 2023 | Pantheris |
| Portola Pharmaceuticals, LLC | $20.36 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.11 | 2019 | |
| Lantheus Medical Imaging, INC. | $15.57 | 2020 | |
| Edwards Lifesciences Corporation | $12.74 | 2020 | |
| Irhythm Technologies, INC. | $12.46 | 2021 | |
| Hologic INC | $11.50 | 2020 | |
| Cardiovascular Systems INC. | $9.51 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$11,225.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$97,185.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devi Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.